OKUR

OnKure Therapeutics, Inc. Class A Common Stock

32 hedge funds and large institutions have $38.4M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.52%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
4
Increased
4
Reduced
11
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
State Street
26
State Street
Massachusetts
$38.2K
BFM
27
Boothbay Fund Management
New York
$37.2K
Northern Trust
28
Northern Trust
Illinois
$27.7K
TRCT
29
Tower Research Capital (TRC)
New York
$14K +$14K +592 New
Wells Fargo
30
Wells Fargo
California
$2.94K
Bank of America
31
Bank of America
North Carolina
$1.35K -$39.4K -1,698 -97%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$45 +$3 +113 +6%
Citadel Advisors
33
Citadel Advisors
Florida
-$490K -14,615 Closed
RC
34
RBF Capital
California
-$49K -1,454 Closed
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
-$37K -1,106 Closed
Citigroup
36
Citigroup
New York
-$25K -750 Closed